Inter Pharma PCL Stock

Inter Pharma PCL EBIT

The EBIT of Inter Pharma PCL (IP.BK) as of Aug 6, 2026 is 171.40 M THB. In the previous year, EBIT was 75.53 M THB — a change of 126.93% (higher).

EBIT

171.40 MTHB

YoY

126.93%

Last updated:

In 2026, Inter Pharma PCL's EBIT was 171.40 M THB, a 126.93% increase from the 75.53 M THB EBIT recorded in the previous year.

The Inter Pharma PCL EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M THB)
Date
EBIT (M THB)
Jan 1, 2018
40.96 base
Jan 1, 2019
61.54 base
Jan 1, 2020
78.33 base
Jan 1, 2021
145.77 base
Jan 1, 2022
171.70 base
Jan 1, 2023
109.40 base
Jan 1, 2024
75.53 base
Jan 1, 2025
171.40 base
YEAREBIT (M THB)
2025 171.40
2024 75.53
2023 109.40
2022 171.70
2021 145.77
2020 78.33
2019 61.54
2018 40.96
2017 28.64
2016 27.38
2015 17.94
Access this data via the Eulerpool API

Inter Pharma PCL Revenue

Inter Pharma PCL Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
313.64 M THB
40.96 M THB
29.68 M THB
Jan 1, 2019
371.33 M THB
61.54 M THB
43.47 M THB
Jan 1, 2020
442.10 M THB
78.33 M THB
52.54 M THB
Jan 1, 2021
908.63 M THB
145.77 M THB
105.22 M THB
Jan 1, 2022
1.52 B THB
171.70 M THB
118.88 M THB
Jan 1, 2023
1.78 B THB
109.40 M THB
50.79 M THB
Jan 1, 2024
1.90 B THB
75.53 M THB
37.28 M THB
Jan 1, 2025
2.19 B THB
171.40 M THB
122.38 M THB

Inter Pharma PCL Margins

Inter Pharma PCL stock margins

The Inter Pharma PCL margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Inter Pharma PCL. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Inter Pharma PCL.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
60.13 %
13.06 %
9.46 %
Jan 1, 2019
57.61 %
16.57 %
11.71 %
Jan 1, 2020
59.01 %
17.72 %
11.88 %
Jan 1, 2021
44.11 %
16.04 %
11.58 %
Jan 1, 2022
40.60 %
11.27 %
7.80 %
Jan 1, 2023
37.02 %
6.14 %
2.85 %
Jan 1, 2024
37.42 %
3.98 %
1.96 %
Jan 1, 2025
37.41 %
7.81 %
5.58 %

Inter Pharma PCL Stock analysis

What does Inter Pharma PCL do? Inter Pharma PCL is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Inter Pharma PCL's EBIT

Inter Pharma PCL's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Inter Pharma PCL's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Inter Pharma PCL's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Inter Pharma PCL’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Inter Pharma PCL stock

EBIT of Inter Pharma PCL is 171.40 M THB in 2026.

EBIT of Inter Pharma PCL changed from 75.53 M THB to 171.40 M THB, representing a 126.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Inter Pharma PCL since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's THB is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Inter Pharma PCL historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Inter Pharma PCL

All Key Metrics — Inter Pharma PCL